Muscle MRI with AI for neuromuscular diseases
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study uses artificial intelligence to analyze muscle MRI scans in people with genetically confirmed neuromuscular diseases. It aims to improve how these conditions are diagnosed and tracked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed genetic test showing you have a neuromuscular disease.
- You must be at least 18 years old.
- You must be able to have an MRI (no metal implants, pacemaker, or other barriers).
- You should not have any other muscle disorder that could interfere with the MRI results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans and blood or other biomarkers to better understand muscular dystrophy in people with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). It may help researchers track disease changes and identify measurable markers over time.
This study uses brain and muscle scans, thinking tests, and muscle assessments to understand how the absence of the Dp140 protein affects people with Becker muscular dystrophy. You may be able to join if you have this condition, can walk, and are interested in helping doctors learn more.
This study looks at muscle MRI images and walking patterns (3D gait analysis) in people with FSHD. It helps researchers understand how the disease affects movement and muscle over time.
This study tests whether special MRI scans can help evaluate neuromuscular (muscle/nerve) diseases. It may help doctors better assess muscle involvement and support diagnosis and evaluation.
This study uses MRI scans to measure muscle changes in people with myotonic dystrophy (DM1 or DM2) and healthy volunteers. The goal is to find better ways to track the disease over time.
This study uses advanced computer models to better understand inherited neuromuscular diseases. It may help doctors find new ways to group patients and personalize care.
Hear when a new Becker Muscular Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.